Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Calskel Nutra
- Development stage
- Unknown
- Lead developer
- Charak
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Calskel Nutra is a marketed nutraceutical calcium supplement developed by Charak. It is formulated to support and maintain optimal bone health, build bone mass during adolescence, fulfill increased calcium requirements during pregnancy and lactation, and minimize the risk of osteoporosis in elderly and post-menopausal individuals. The supplement contains a combination of essential minerals and vitamins, including calcium, magnesium, zinc, and vitamin D3, alongside traditional Ayurvedic herbs such as Hadjod (Cissus quadrangularis) and Marich (Piper nigrum) to enhance calcium absorption and bone metabolism.
- Brand names
- Calskel Nutra
- Other names
- Calskel Nutra TabletCalskel Nutra Tablets
02
Targets
CaSR (Extracellular calcium-sensing receptor)VDR (Vitamin D receptor)
Beyond the preview
Go deeper on Calskel Nutra.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Calskel Nutra.